Company / Goodwill
Vir Biotechnology, Inc. Goodwill History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$16.9M
FY2025
5-year range
$16.9M / $16.9M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#56 of 74
Health Care
What the data says
Vir Biotechnology, Inc.'s goodwill of $17M is lower than 76% of companies in the Health Care sector (FY2025). Goodwill remained relatively stable over the past 8 years, with values between $17M and $17M.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of +0.0%.
Remained stable around $17M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 74This company $16.9M Sector average $4.0B
▼
-99.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.0%, indicating consistent growth.
- In FY2025, goodwill increased 0.0% year-over-year.
- Ranks #56 out of 74 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.9M | +0.0% |
| FY2024 | $16.9M | +0.0% |
| FY2023 | $16.9M | +0.0% |
| FY2022 | $16.9M | +0.0% |
| FY2021 | $16.9M | +0.0% |
| FY2020 | $16.9M | +0.0% |
| FY2019 | $16.9M | +0.0% |
| FY2018 | $16.9M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026